Studies on the Different Modes of Action of the Anticoagulant Protease Inhibitors DX-9065a and Argatroban
Open Access
- 1 December 2002
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (52) , 50445-50449
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Studies on the Different Modes of Action of the Anticoagulant Protease Inhibitors DX-9065a and ArgatrobanJournal of Biological Chemistry, 2002
- Thrombin-Activatable Fibrinolysis Inhibitor (TAFI, Plasma Procarboxypeptidase B, Procarboxypeptidase R, Procarboxypeptidase U)Thrombosis Research, 2001
- Comparison of Argatroban and Hirudin for the Reperfusion of Thrombotic Arterial Occlusion by Tissue Plasminogen ActivatorJournal of Thrombosis and Thrombolysis, 1998
- Plasma and Recombinant Thrombin-activable Fibrinolysis Inhibitor (TAFI) and Activated TAFI Compared with Respect to Glycosylation, Thrombin/Thrombomodulin-dependent Activation, Thermal Stability, and Enzymatic PropertiesJournal of Biological Chemistry, 1998
- Factor XI and Protection of the Fibrin Clot against Lysis – a Role for the Intrinsic Pathway of Coagulation in FibrinolysisThrombosis and Haemostasis, 1998
- Thrombin, Thrombomodulin and TAFI in the Molecular Link Between Coagulation and FibrinolysisThrombosis and Haemostasis, 1997
- Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis.Journal of Clinical Investigation, 1997
- TAFI, or Plasma Procarboxypeptidase B, Couples the Coagulation and Fibrinolytic Cascades through the Thrombin-Thrombomodulin ComplexJournal of Biological Chemistry, 1996
- Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysisBlood, 1995
- Selective inhibition of thrombin by (2R,4R)-4-methyl-1-[N2-[1,2,3,4-tetrahydro-8-quinolinyl)sulfonyl]-L-arginyl]-2-piperidinecarboxylic acidBiochemistry, 1984